| Combination Therapy for Recurrent Ovarian Cancer | Combination Therapy with Liposomal Doxorubicin and Withaferin a (Ashwagandha, ASWD) in Recurrent Ovarian Cancer | NCT05610735 |
| Study of Standardized Withaferin-A for the treatment of Steroid Refractory acute Graft versus Host Disease. | A Phase II Clinical Trial of Standardized Withaferin-A for the treatment of Steroid Refractory acute Graft versus Host Disease. | CTRI/2023/07/055361 |
| Study to evaluate the Safety and Effectiveness of Withaferin A as a treatment to Prevent GvHD in Transplant Patients | A Phase I/II trial to assess Safety and Activity of Standardized Withaferin A as GvHD prophylaxis in patients undergoing Matched related donor Hematopoietic stem cell transplant - NIL | CTRI/2024/12/078211 |
